TrumpRx Expansion Fact-Checked: Drugs, Iran & More

Trump Expands TrumpRx to 600+ Generic Drugs, Announces Home Delivery and New Industry Partners at White House Healthcare Event

President Donald Trump held a White House Healthcare Affordability Event on May 18, 2026, to announce a sweeping expansion of TrumpRx.gov — the administration’s prescription drug price-transparency website — adding more than 600 low-cost generic drugs, new pharmacy map tools, and fast home-delivery options through partnerships with Cost Plus Drugs, Amazon Pharmacy, and GoodRx. Trump used the occasion to tout his Most Favored Nation (MFN) drug pricing policy, which he claims has moved the United States from the world’s highest drug prices to its lowest, and to take questions on a wide range of breaking news topics — including a potential Iran nuclear deal, a DOJ compensation fund for January 6 defendants, an Ebola case involving an American, a mosque shooting in San Diego, and election integrity concerns over Maryland’s mail-in ballot controversy. Assistance from Claude AI.

Participants

Name	Title
Donald Trump	President of the United States
Robert F. Kennedy Jr.	Secretary of Health and Human Services
Dr. Mehmet Oz	Administrator, Centers for Medicare and Medicaid Services (CMS)
Chris Klomp	Chief Counselor, Department of Health and Human Services
Joe Gebbia	Airbnb Co-Founder; Chief Design Officer of the United States / National Design Studio
Mark Cuban	Co-Founder, Cost Plus Drugs
Tanvi Patel	Vice President, Amazon Pharmacy
Aaron Crittenden	President, Rx Marketplace at GoodRx
Heidi Overton	Public Health Official (introduced by Dr. Oz to address Ebola question)
Ed Coristine	National Design Studio (mentioned by Trump)

Topic-by-Topic Breakdown

1. TrumpRx.gov: Launch History and Early Results

Trump opened by recapping the February 2026 launch of TrumpRx.gov, which he described as “the largest discounts on prescription drugs in the history of our country — history, frankly, of any country.”

He framed the achievement in stark terms: “For decades, Americans paid the highest drug prices anywhere in the world by far. But under the Most Favored Nation agreements I negotiated, we now pay the lowest price paid for anybody in any country. We went from the highest to the lowest.”

⚑ FACT-CHECK — “Highest to lowest”: ⚠️ Misleading — Accurate in narrow scope, overstated as a universal claim.

The first half of the claim has strong support. A 2024 RAND Corporation study commissioned by the Department of Health and Human Services found that across all drugs, U.S. prices were nearly 2.78 times higher than those in 33 OECD comparison countries in 2022, and brand-name drugs averaged more than 3.22 times the international price even after rebate adjustments (HHS/ASPE & RAND, 2024). The U.S. did pay the highest prices for brand-name drugs among developed nations — that is well-documented.

However, the claim that the U.S. “now pays the lowest price” is a significant overstatement. TrumpRx operates as a cash-pay, direct-to-consumer platform covering negotiated deals with 17 major manufacturers. Independent analysts, including the Kaiser Family Foundation and health economists at the University of Washington, note that roughly 85% of Americans have prescription drug insurance coverage and may see little or no benefit from TrumpRx prices, since TrumpRx purchases typically bypass insurance and do not count toward deductibles or out-of-pocket maximums (KFF, 2026; STAT News, 2026). Drug price tracker 46brooklyn found that close to 1,000 brand-name drugs still went up in price in January 2026 (KFF Health News, 2026). The accurate picture: TrumpRx delivers meaningful discounts for a specific subset of drugs to uninsured or cash-paying consumers; it has not restructured drug pricing across the entire U.S. market.

Trump cited a series of statistics:

The site has been visited more than 10 million times since its February launch.
It has already saved American consumers over $400 million.

⚑ FACT-CHECK — “10 million visits / $400 million saved”: ℹ️ Unverifiable — Administration-reported figures, no independent audit.

These figures come from the administration’s own reporting and have not been independently verified. The White House Fact Sheet issued the same day (May 18, 2026) repeats both numbers but cites no external auditor. Visitor and savings figures on government platforms are self-reported by the agency running them. The numbers are plausible in direction given the program’s scale but cannot be confirmed as accurate without independent review.

The Council of Economic Advisers projects MFN drug policies will save Americans over $500 billion over the next 10 years.

⚑ FACT-CHECK — “$500 billion, 10-year savings”: ⚠️ Accurate-with-context — From White House’s own projections, not independent.

The White House’s Council of Economic Advisers published a report projecting $529 billion in savings from “prospective MFN” (new drug launches) plus $64.3 billion from Medicaid pricing over 10 years (White House CEA, 2026). Trump’s $500 billion figure is consistent with that internal projection. However, as the same report acknowledges, the voluntary agreements underpinning TrumpRx have no legislative enforcement mechanism, and proposed legislation to codify them remains pending in Congress (Klomp remarks, May 18, 2026). The long-term savings figure is therefore a projection contingent on agreements holding and legislation passing — not a realized or guaranteed outcome.

Drug prices on specific medications have been cut by 400, 500, 600, and even 700 percent compared to previous U.S. pricing — covering weight loss drugs, fertility treatments, insulin, and more.

⚑ FACT-CHECK — “400–700% price reductions”: ❌ Mathematically incorrect framing.

This claim confuses percentage-off with percentage-of-original-price. A drug that drops from $1,000 to $350 — as Ozempic did on TrumpRx — is a 65% discount, not a “700 percent” reduction. A price cannot be reduced by more than 100% and still have a positive value. CNN’s fact-checkers noted a nearly identical claim from a prior Trump event, observing that his own officials could not explain the math — Dr. Oz said at one point, “I don’t know what the math is on that. We can’t even calculate it” (CNN, 2025). The actual discounts on TrumpRx are substantial for the drugs included — ranging from 50% to over 90% off list price in some cases — but framing them as “400 to 700 percent” reductions is mathematically incorrect.

Trump also claimed this was the “first time in 28 years” drug prices fell during his first term.

⚑ FACT-CHECK — “First time in 28 years” (first-term drug prices): ✅ Mostly Accurate — With important context.

During Trump’s first term, the Consumer Price Index for prescription drugs did record a year-over-year decline of approximately 2.0% in 2019, which the White House at the time described as the largest single-year CPI drop since 1967 (Trump White House Archives, 2019). The “28 years” formulation is roughly consistent with that framing. However, fact-checkers at the time noted this measure reflected aggregate CPI movement — and that even as the overall index dipped slightly, the list prices of thousands of individual brand-name drugs continued rising (PolitiFact, 2019).

Context for general readers: The “Most Favored Nation” (MFN) pricing concept means the U.S. government negotiates to pay no more for a drug than the lowest price paid by any other developed country. For years, Americans famously paid far more than Canadians, Europeans, or Australians for the same brand-name drugs made in the same factories. The MFN approach is an attempt to force pharmaceutical companies to equalize those prices.

2. The Big Announcement: 600+ Generics Added, Site Now 7x Larger

The headline announcement of the event was a sevenfold expansion of the TrumpRx.gov formulary.

Trump stated: “Today, I’m thrilled to announce that we’re increasing the number of drugs available on TrumpRx by nearly seven times, adding over 600 affordable generics to the website, working with industry partners.”

He made the case for generics directly to consumers: “In theory, they’re the same thing. Sometimes they’re better, with the same dosage, the same effectiveness, and the same active ingredients — yet many consumers do not think to ask for them. They don’t know about them.”

He positioned the expanded site as a price-checking tool: “TrumpRx.gov should always be your first stop before you go to the pharmacy to pick up your prescription… at a minimum, you’ll know what you’re supposed to be paying.”

⚑ FACT-CHECK — TrumpRx as universal “first stop” / cheapest option: ⚠️ Misleading for most insured patients.

For uninsured patients or those buying drugs not covered by insurance (such as GLP-1 weight loss drugs for many plans), TrumpRx prices can represent significant savings. However, the KFF found that for privately insured patients, using TrumpRx — a cash-pay channel — often costs more than using insurance copays, and purchases do not count toward annual deductibles or out-of-pocket maximums (KFF, 2026). In one illustrative scenario KFF analyzed, a patient paying a $30 copay through insurance would spend $360/year; using TrumpRx for the same drug at its discounted cash price would cost over $1,186/year. Uninsured patients and those buying drugs outside insurance coverage are the program’s primary beneficiaries.

Context: A generic drug contains the same active ingredient at the same dose as the brand-name version but is typically sold at a fraction of the price once the original manufacturer’s patent expires. Consumer advocates have long argued that many Americans overpay for brand-name drugs without realizing equivalent generics exist.

Dr. Oz confirmed the specific count: “Today, 601 more medications were added, 601 more.” He added: “We believe that more than half of all the prescription interactions in America are now going to be revealed on TrumpRx.”

3. New Features: Map Search, Price Comparison, and Home Delivery

Joe Gebbia, Airbnb co-founder and the administration’s Chief Design Officer, gave a live demonstration of the updated TrumpRx website, walking through its key new features.

Gebbia’s demo highlights:

“Presidential Deals” section: A new curated section featuring deeply discounted brand-name drugs. He cited specific examples:
- Foundayo (a new GLP-1 pill): 77% off
- An insulin medication: 72% off
- Trulicity (diabetes): 61% off
Brand-to-generic search: Users can now type in a brand-name drug and see the generic alternative. Gebbia demonstrated with Glucophage (a diabetes drug, roughly $20): the site surfaced Metformin, the generic equivalent, priced at $8.42.
Map search: A new pharmacy map allows users to compare prices at both chain pharmacies and independent local pharmacies on the same screen. Gebbia demonstrated finding a $18 option at one pharmacy and an $8.42 option at a pharmacy a block away.
Coupon integration: Once a user finds the best price, they can take a coupon directly from the site to their pharmacist.
Home delivery: New partnerships enable fast prescription delivery to the user’s door, with Gebbia noting: “I can actually get this medicine to my door in a day or so.”

Gebbia summarized the vision: “You compare prices on flights, why not medicine? Don’t just fill your prescription — TrumpRx it.”

4. Industry Partners: Cost Plus Drugs, Amazon Pharmacy, GoodRx

Trump welcomed three major private-sector partners to the stage.

Mark Cuban — Cost Plus Drugs

Mark Cuban, the entrepreneur and co-founder of Cost Plus Drugs, received a warm and notably bipartisan introduction. Trump called him by name: “Mark, looking good. Come here.”

Cuban endorsed the program with explicit political framing: “Republicans want cheaper drugs, independents want cheaper drugs, Democrats want cheaper drugs. And together, I think we’re going to do something special.”

He explained what distinguishes Cost Plus Drugs from standard pharmacies: “When you click through TrumpRx to our site, not only will you see a great price, but you’ll see our actual cost and that we only mark it up 15 percent.”

He also noted a volume-based pricing dynamic: “As our volumes go up, our costs go down, which means we’ll be ending up charging less to people over a period of time.”

Cuban confirmed that 559 of the 601 newly added generic drugs are Cost Plus Drugs products.

Context: Cost Plus Drugs was founded by Mark Cuban in 2022 on the premise of radical price transparency — publishing the actual cost of each drug and adding only a fixed markup. It became a notable force in the generic drug market and attracted bipartisan praise. Cuban endorsed Democratic candidate Kamala Harris in the 2024 presidential race, making his appearance at this Trump White House event a notable political moment (addressed later in the press Q&A).

Tanvi Patel — Amazon Pharmacy

Tanvi Patel, Vice President of Amazon Pharmacy, said: “At Amazon Pharmacy, it’s been our mission to build a pharmacy with price transparency from day one, and it’s been our mission to make sure that Americans who need their medications know how much they’re going to pay out of pocket for brand or generic medications — whether you’re paying cash or insurance.”

Aaron Crittenden — GoodRx

Aaron Crittenden, President of the Rx Marketplace at GoodRx, kept his remarks brief: “We have a shared mission, as everyone up here, to deliver health care that’s affordable to every American.”

5. Secretary Kennedy on Chronic Disease and National Security

HHS Secretary Robert F. Kennedy Jr. opened his remarks with a stark public health framing.

On the scope of the chronic disease crisis: “If you include my agency plus Social Security and the VA, Americans now spend $0.48 out of every dollar that we spend in federal taxes — now go to health care. 90 percent of that is for chronic disease. And those costs are increasing at two percent greater speed than the GDP.”

He escalated to a national security warning: “77 percent of American kids cannot qualify for military service.”

⚑ FACT-CHECK — “77 percent of kids cannot qualify for military service”: ✅ Accurate — From a 2020 Pentagon study.

Kennedy’s figure matches the Pentagon’s own 2020 Qualified Military Available Study, which found that 77% of Americans aged 17 to 24 would be ineligible for military service without a waiver — an increase from 71% in 2017 (Military.com / Pentagon, 2022; Council for a Strong America, 2023). The most common disqualifying factors were obesity (11%), drug and alcohol abuse (8%), and physical or medical conditions (7%), with 44% of ineligible youth disqualified for multiple reasons. The figure is well-sourced from DOD data, though it dates from 2020 and may not reflect any changes since then.

Kennedy praised Trump’s drug pricing results in direct comparison to predecessors: “President Bush promised to do this. President Clinton promised to do it. President Biden promised to do it. President Obama promised to do it. President Trump actually got it done. And it’s an extraordinary accomplishment.”

⚑ FACT-CHECK — Predecessors “promised but failed” on drug pricing: ✅ Mostly Accurate — With important distinctions.

It is accurate that multiple administrations pursued drug pricing reform without achieving the scale of MFN-style reductions. The Biden administration’s Inflation Reduction Act (2022) did authorize Medicare to negotiate drug prices for the first time — a landmark change — and the first 10 negotiated prices took effect January 1, 2026 (Georgetown Medicare Policy Initiative, 2026). The Trump claim that he “actually got it done” while others failed is defensible in terms of the MFN voluntary agreement framework and TrumpRx platform, though independent experts note the agreements are voluntary and unlegislated (CBS News, 2026). The Biden IRA negotiations, which remain in effect, represent a parallel achievement on Medicare drug pricing that this framing omits.

Context: Kennedy framed drug pricing not just as a pocketbook issue but as part of his larger “Make America Healthy Again” agenda, which argues that chronic disease — driven by diet, medications, and environmental factors — represents an existential threat to both the economy and military readiness.

6. Dr. Oz on Affordability and Market Transparency

Dr. Mehmet Oz, CMS Administrator, offered a physician’s-eye view on the problem being solved.

He cited a striking consumer statistic: “Almost one in three Americans, when they go to a drugstore, cannot afford to pick up the medications that their doctor prescribed for them.”

⚑ FACT-CHECK — “One in three Americans cannot afford their prescriptions”: ⚠️ Partially Accurate — Credible but differs by population.

KFF polling from 2025 found that more than 1 in 4 adults under age 65 report difficulty affording their medication, with significantly higher rates among the uninsured and those with individual market coverage (KFF, 2026). The “one in three” figure is at the higher end of available polling but is broadly consistent with the problem’s documented scale. The precise share depends on how “cannot afford” is defined and which population is measured.

He described how the MFN policy exposed the core inequity: “We’re paying three times more for the exact same drugs made in the same facilities, often in this country, than people overseas are paying for those exact same drugs.”

⚑ FACT-CHECK — “Three times more than other countries”: ✅ Accurate for brand-name drugs.

The RAND/HHS study using 2022 data found that U.S. prices for brand-name drugs were at least 3.22 times higher than in 33 OECD comparison countries, even after adjusting for rebates (ASPE/RAND, 2024). “Three times more” is consistent with the evidence for brand-name drugs. Note that for unbranded generics, U.S. prices were actually about 33% lower than the international comparison group — a nuance not mentioned at the event (RAND, 2024).

7. Chris Klomp on Savings Numbers and the Road Ahead

Chris Klomp, HHS Chief Counselor, put specific dollar figures on what the expanded program means for families.

A family currently taking a GLP-1 weight loss drug will save approximately $1,800 per year compared to four months ago.
A family needing fertility medications will save nearly $6,000 per live birth, which he projected adds up to $5 billion going to hopeful parents over the next decade.

⚑ FACT-CHECK — GLP-1 savings / fertility savings: ✅ Plausible for target population — Unverifiable independently, cash-pay context applies.

The $1,800 GLP-1 savings figure is consistent with documented list-price reductions. Under MFN deals, Ozempic dropped to approximately $350/month from a list price of roughly $1,000/month, representing roughly a $7,800 annual difference at list price (Georgetown Medicare Policy Initiative, 2026). An $1,800 annualized savings number would reflect a more modest but real price reduction depending on which drug and baseline are used. For fertility drugs, EMD Serono’s Gonal-F and Cetrotide were among the original TrumpRx launch drugs with substantial price cuts. However, the savings apply specifically to cash-pay patients; insured patients may or may not benefit depending on their coverage. The $5 billion projection over a decade is a White House estimate and has not been independently verified.

Klomp outlined three priorities going forward:

More industry partners: HHS has been “inundated with demand” from small and mid-size biotech and pharmaceutical companies wanting to offer MFN prices.
International trade agreements: Ongoing negotiations are “well underway, working lockstep with partners at trade and commerce.”
Legislation: Active discussions are underway on Capitol Hill to codify drug pricing reforms.

Klomp closed: “The foundation is built, the market is engaged, the future is affordable.”

8. Press Q&A — San Diego Mosque Shooting

A reporter asked about a shooting at a mosque in San Diego.

Trump: “They’re giving a briefing on it a little while — at the mosque. They’re giving a briefing, and it’s a terrible situation. I’ve been given some early updates, but we’re going to be going back and looking at it very strongly.”

Note: Trump provided no further details. A formal briefing was described as forthcoming.

9. Press Q&A — Iran: A Military Strike Postponed

One of the most consequential moments of the press Q&A came when a reporter asked about a Trump post on Truth Social regarding Iran.

Trump revealed that the U.S. had been prepared to conduct “a very major attack tomorrow” on Iran, but had postponed it at the request of regional allies.

“I was asked by Saudi Arabia, Qatar, UAE and some others, if we could put it off for two or three days, a short period of time, because they think that they are getting very close to making a deal.”

Trump described the goal: “If we can do that, where there’s no nuclear weapon going into the hands of Iran, I think — and if they’re satisfied, we will be probably satisfied also.”

He stated that Israel and other Middle East partners had been informed of the delay.

When pressed on past deals that hadn’t materialized, Trump said: “We’ve had periods of time where we thought pretty much getting close to making a deal and it didn’t work out, but this is a little bit different.”

⚑ FACT-CHECK — “This time is different”: ⚠️ Disputed — Trump has postponed Iran strikes at least half a dozen times.

Axios reported on May 18, 2026, that “Trump has extended deadlines and postponed planned attacks on Iran at least half a dozen times since the war began,” and that the White House had seen an updated Iranian peace proposal as insufficient before Trump made his announcement (Axios, 2026). The broader conflict context: According to Wikipedia’s documented timeline and UK House of Commons Library research briefings, the U.S. and Israel launched large-scale strikes on Iran beginning February 28, 2026, under Operation Epic Fury, including the assassination of Supreme Leader Ali Khamenei. A conditional ceasefire was declared April 8, 2026, and brokered by Pakistan; Iran subsequently refused to reopen the Strait of Hormuz, triggering a U.S. naval blockade (Wikipedia: 2026 Iran war). The claim that “this time is different” is not independently verifiable and has been made repeatedly with mixed results. Multiple independent observers note the pattern of deadline extensions.

He described the military results to date: “We’ve taken a country that was going to have a nuclear weapon and we’ve virtually destroyed its military. They have no Navy. They have no Air Force.”

⚑ FACT-CHECK — “No Navy, no Air Force”: ⚠️ Partially Accurate — Substantial military damage confirmed; “no” Navy/Air Force overstates.

The U.S.-Israel military campaign has caused extensive, documented damage to Iran’s military infrastructure. UK House of Commons Library research confirms the strikes targeted military facilities and defenses, resulting in significant degradation of Iranian capabilities (Commons Library, 2026). The International Atomic Energy Agency has been unable to resume inspections of Iran’s damaged nuclear sites. However, the claim that Iran has literally “no Navy” and “no Air Force” is an overstatement; Iran has continued launching missiles and drones against Gulf states and Israel even after the campaign, indicating functional military capability remains (Al Jazeera liveblog, May 18, 2026; Wikipedia: 2026 Strait of Hormuz crisis). The accurate characterization is that Iran’s military was severely degraded, not eliminated.

He cited a naval blockade: “We built, really, a steel wall — a blockade — where no boats are able to… not one boat has been able to get through our blockade.”

⚑ FACT-CHECK — Naval blockade: ✅ Confirmed — Context needed.

According to the Wikipedia timeline of the 2026 Strait of Hormuz crisis, Trump announced a U.S. naval blockade of Iran from April 13, 2026, creating a “dual blockade” situation — the U.S. Navy blockading Iran while Iran simultaneously blockaded the Persian Gulf’s Strait of Hormuz (Wikipedia: 2026 Strait of Hormuz crisis). The blockade is a confirmed development; its complete effectiveness (“not one boat”) is unverifiable through open sources.

On why he was willing to hold off: “If we can do that without bombing the hell out of them, I’d be very happy.”

Context for general readers: The 2026 Iran war began on February 28, 2026, when the U.S. and Israel launched coordinated airstrikes targeting Iran’s military infrastructure, nuclear sites, and leadership — resulting in the death of Supreme Leader Ali Khamenei. Iran responded with missile and drone strikes on Israel, U.S. military bases, and Gulf Arab states. Iran closed the Strait of Hormuz — a critical global oil shipping lane — in retaliation. A Pakistani-brokered ceasefire was declared April 8, 2026, but remained fragile. As of May 18, Trump revealed a new military strike had been planned for May 19 before Gulf states intervened to request a diplomatic pause.

10. Press Q&A — January 6 DOJ Compensation Fund

A reporter asked about a $1.7 billion Justice Department fund reportedly announced that day to compensate January 6 defendants.

Trump said he had little involvement in creating it: “I know very little about it. I wasn’t involved in the whole creation of it and the negotiation.”

He defended the concept: “This is reimbursing people that were horribly treated… It’s anti-weaponization. They’ve been weaponized. They’ve been, in some cases, imprisoned wrongly. They paid legal fees that they didn’t have. They’ve gone bankrupt. Their lives have been destroyed.”

When asked pointedly whether people who committed violence against Capitol Police officers on January 6 should be eligible, Trump said: “It’ll all be dependent on a committee. A committee is being set up, of very talented people, very highly respected people. I think it’s a committee of five.”

When asked whether he or his family members would seek compensation from the fund, Trump did not directly answer.

Context: January 6, 2021, saw a mob of Trump supporters breach the U.S. Capitol in an effort to disrupt certification of the 2020 election. More than 1,200 people were charged with federal crimes. Trump has consistently characterized prosecutions as politically motivated “weaponization” of the justice system. A DOJ fund to compensate defendants represents a significant and likely contested policy action. Trump’s claim that he “wasn’t involved” in creating it is unverifiable.

11. Press Q&A — Mark Cuban and Political Crossover

A reporter noted the “remarkable” optics of Trump and Mark Cuban appearing together, given that Cuban had endorsed Kamala Harris in the 2024 presidential election.

Trump: “Well, he made a mistake. It was a big mistake.”

Then, more generously: “It says we love people, we love our country… Mark wanted to be a part of it. And I think Mark was very gracious… I have a lot of respect for Mark, frankly, and I always have.”

12. Press Q&A — Ebola: An American Tests Positive, Entry Restrictions Imposed

When a reporter asked whether Americans should be concerned about Ebola, Trump deferred to Dr. Heidi Overton, a public health official introduced by Dr. Oz.

Overton disclosed several significant developments:

An American has tested positive for the Bundibugyo virus, a strain of Ebola. That individual, along with six high-risk contacts, will be evacuated and transported to Germany for treatment.
The U.S. government has issued travel warnings for affected regions.
Entry restrictions for non-U.S. citizens who have been in Uganda, Democratic Republic of Congo, and South Sudan within the past 21 days were instituted the same day.
A full interagency response has been stood up, involving the State Department, CDC, and Department of Defense.
“Right now, there are no cases of Ebola in America. We want to keep it that way.”

⚑ FACT-CHECK — Ebola response claims: ✅ Accurate — Corroborated by CDC press briefing the same day.

Overton explicitly stated that a CDC press briefing held May 18, 2026, disclosed these same details. The announcement of a positive Bundibugyo virus case in an American and the interagency response measures described appear consistent with standard public health practice for suspected viral hemorrhagic fever cases. The specific entry restriction and evacuation details could not be independently confirmed via additional sources in the time available, but were delivered by a government health official at an official White House briefing and are consistent with prior U.S. responses to Ebola-adjacent cases.

13. Press Q&A — Election Integrity and Maryland Mail-In Ballots

A reporter asked Trump about his concerns regarding the Maryland primary election and mail-in ballots.

Trump expressed strong concerns: “I’m very concerned about mail-in ballots. We’re the only country in the world that’s doing mail-in ballots.”

⚑ FACT-CHECK — “Only country doing mail-in ballots”: ❌ False.

Mail voting is used in numerous countries, including Switzerland (where it is the dominant voting method), Germany, Austria, the United Kingdom, France, New Zealand, and Australia, among others. The U.S. is not unique in permitting or using mail-in voting. This claim has been made repeatedly by Trump and has been rated false by multiple fact-checkers.

He described the specific Maryland situation: “In Maryland, 500,000 fake ballots were sent out. When they were caught, they said, ‘Oh, we’ll pull them back.’ And they issued 500,000 new ballots. And as you know, they never got the original ballots back. So there are a million ballots out there.”

⚑ FACT-CHECK — “500,000 fake ballots” in Maryland: ❌ Significantly Misleading — Vendor printing error, not fraudulent ballots.

The Maryland State Board of Elections confirmed on May 15, 2026, that a printing vendor (Taylor Print & Visual Impressions) made an error in which some voters received the wrong party’s ballot for the upcoming June 23 Gubernatorial Primary (Maryland SBE, 2026). The Board explicitly stated: “It is possible only a small number of voters received the wrong ballot, and most voters received the correct ballot.” Out of an abundance of caution, all 500,000+ mail-in ballot recipients are being sent replacement ballots — a standard election integrity safeguard.

The ballots were not “fake” — they were legitimate official ballots containing a printing error. They were not intentionally fraudulent. The Maryland State Administrator of Elections, Jared DeMarinis, said the replacement effort was designed precisely to “eliminate any doubt” about integrity, and warned that “the situation might cause the spread of misinformation” (Maryland SBE, 2026; WTOP News, 2026). Trump’s characterization of these as “500,000 fake ballots” is a significant misrepresentation of what occurred.

Trump’s additional claim that “they never got the original ballots back” and that “a million ballots are out there” combines a speculative worst-case assumption with the misleading “fake ballot” framing. The SBE noted that if a voter already returned the first (erroneous) ballot, local election offices are “able to identify these ballots and secure them” (Maryland SBE, 2026).

He said: “I’ve asked the law enforcement to look at it very, very strenuously.”

14. Closing Remarks

Trump closed the formal event with thanks to the assembled team:

“I want to thank Bobby and Oz and Mark and all of the people that are here. And Joe — great job. You are really something. I heard about you for a long time, and now you’re doing something that’s more important than anything you’ve ever done, and you’ve done some beauties.”

Notable Exchanges and Moments

Trump and Cuban: The image of Trump warmly praising a man who publicly endorsed his 2024 opponent — and Cuban reciprocating — was the event’s most visually striking political moment. Cuban showed no hesitation in standing alongside the president and enthusiastically endorsing the TrumpRx program.
Iran revelation: What was billed as a drug pricing event became, during Q&A, the venue for a significant foreign policy disclosure: the U.S. was within roughly 24 hours of a major Iran military strike before Gulf allies requested a pause for diplomacy.
Ebola disclosure: The announcement that an American had tested positive for Ebola and that entry restrictions had been imposed came through a brief Q&A answer at a healthcare affordability event — an unconventional venue for a public health announcement of that magnitude.
Kennedy’s framing: RFK Jr.’s comparison of Trump’s drug pricing achievement to broken promises by four previous presidents was among the event’s most rhetorically pointed moments.

Fact-Check Summary Table

Claim	Speaker	Verdict
U.S. “went from highest to lowest” drug prices	Trump	⚠️ Misleading — Accurate for specific drugs/cash-pay; not system-wide
“400–700% price reductions”	Trump	❌ Mathematically incorrect framing
10 million site visits / $400M saved	Trump	ℹ️ Unverifiable — Admin self-reported, no independent audit
$500B in 10-year savings	Trump	⚠️ Accurate-with-context — White House projection, voluntary & unlegislated
“First time in 28 years” (first-term drug price drop)	Trump	✅ Mostly Accurate — With context
“Three times more” than other countries	Oz	✅ Accurate for brand-name drugs
“One in three can’t afford prescriptions”	Oz	⚠️ Partially Accurate — Consistent with polling; definition-dependent
77% of youth can’t qualify for military service	Kennedy	✅ Accurate — 2020 Pentagon data
Predecessors promised but failed on drug pricing	Kennedy	✅ Mostly Accurate — Biden IRA Medicare negotiations omitted
Iran: “No Navy, no Air Force”	Trump	⚠️ Partially Accurate — Severe damage confirmed; not eliminated
Iran: Naval blockade established	Trump	✅ Confirmed
Iran strike postponement “this time is different”	Trump	⚠️ Disputed — Pattern of repeated extensions documented
“Only country doing mail-in ballots”	Trump	❌ False
Maryland “500,000 fake ballots”	Trump	❌ Significantly Misleading — Vendor printing error, not fraud
Ebola response / American testing positive	Overton	✅ Accurate — Consistent with CDC briefing

Sources

HHS/ASPE & RAND Health Care. (2024, January 31). Comparing prescription drugs in the U.S. and other countries: Prices and availability. https://aspe.hhs.gov/reports/comparing-prescription-drugs
Mulcahy, A. W., et al. (2024, February 1). Prescription drug prices in the U.S. are 2.78 times those in other countries. RAND Corporation. https://www.rand.org/news/press/2024/02/01.html
Kaiser Family Foundation. (2026, February 25). TrumpRx: What’s the value for customers? https://www.kff.org/patient-consumer-protections/trumprx-whats-the-value-for-customers/
Sullivan, S., & Hansen, R. (2026, February 5). Who does TrumpRx actually benefit? STAT News. https://www.statnews.com/2026/02/05/trumprx-prescription-drug-costs-flaws/
KFF Health News. (2026). Trump promised cheaper drugs. Some prices dropped. Many others shot up. https://kffhealthnews.org/health-care-costs/trumprx-reality-check-drugs-not-always-cheaper/
White House Council of Economic Advisers. (2026, May). Savings from Most-Favored-Nation drug pricing policy. https://www.whitehouse.gov/research/2026/05/savings-from-most-favored-nation-drug-pricing-policy/
White House. (2026, May 18). Fact sheet: President Donald J. Trump announces expansion of TrumpRx.gov. https://www.whitehouse.gov/fact-sheets/2026/05/
GovFacts. (2026). TrumpRx: How the drug pricing program works. https://govfacts.org/health-healthcare/drugs-and-medications/prescription-drug-coverage/trumprx-how-the-drug-pricing-program-works/
Georgetown University Medicare Policy Initiative. (2026). Drug pricing in the era of Trump 2.0. https://medicare.chir.georgetown.edu/drug-pricing-in-the-era-of-trump-2-0/
CNN Fact Check. (2025, October 17). Fact check: Five false numbers Trump used at one event. https://www.cnn.com/2025/10/17/politics/fact-check-trump-drug-prices-wars-shutdown
PolitiFact. (2019, May 22). Fact-checking Donald Trump’s claim that drug prices are going down. https://www.politifact.com/factchecks/2019/may/22/donald-trump/
Trump White House Archives. (2019). Prescription drug prices are falling at historic levels. https://trumpwhitehouse.archives.gov/articles/prescription-drug-prices-falling-historic-levels-thanks-trump-administration-policies/
Council for a Strong America. (2023). 77 percent of American youth can’t qualify for military service. https://www.strongnation.org/articles/2006-77-percent-of-american-youth-can-t-qualify-for-military-service
Military.com. (2022, September 28). New Pentagon study shows 77% of young Americans are ineligible for military service. https://www.military.com/daily-news/2022/09/28/new-pentagon-study-shows-77-of-young-americans-are-ineligible-military-service.html
Axios. (2026, May 18). Trump says attack on Iran paused after Gulf states’ requests. https://www.axios.com/2026/05/18/trump-iran-attack-suspend-nuclear-talks
Al Jazeera. (2026, May 18). Iran war updates: Trump says Iran attack held off upon Gulf states’ request. https://www.aljazeera.com/amp/news/liveblog/2026/5/18/iran-war-live
Wikipedia. (2026). 2026 Iran war. https://en.wikipedia.org/wiki/2026_Iran_war
Wikipedia. (2026). 2026 Strait of Hormuz crisis. https://en.wikipedia.org/wiki/2026_Strait_of_Hormuz_crisis
UK House of Commons Library. (2026). US-Iran ceasefire and nuclear talks in 2026. https://commonslibrary.parliament.uk/research-briefings/cbp-10637/
Maryland State Board of Elections. (2026, May 15). Maryland addresses an error with mail-in ballots. https://elections.maryland.gov/press_room/documents/2026/Mail_in_Ballot_Press_Statement.pdf
CBS News Baltimore. (2026). Maryland Board of Elections pushes back on Trump’s claim of 500,000 fake mail-in ballots. https://www.cbsnews.com/baltimore/news/maryland-board-of-elections-trumps-500000-fake-mail-in-ballots/
WTOP News. (2026). Maryland is resending thousands of mail-in primary ballots after a vendor mix-up. https://wtop.com/maryland-election/2026/05/maryland-is-resending-thousands-of-mail-in-primary-ballots-after-a-vendor-mix-up/
Maryland State Board of Elections. (2026). Mail-in ballot replacement information. https://elections.maryland.gov/elections/2026/2026_replacement_mib.html

Citation

“Remarks: Donald Trump Attends a White House Healthcare Affordability Event – May 18, 2026.” Factbase, 18 May 2026, factba.se. Transcript via Roll Call / FiscalNote StressLens.

TrumpRx Expansion Fact-Checked: Drugs, Iran & More — 2026